However, the pipeline of oral and multi-agonist assets from Amgen, Viking Therapeutics, Structure Therapeutics, and others is expanding rapidly
adults reported that they had previously used a GLP-1 medication (Montero, et al., 2024), which has been increasing in popularity (e.g., Regalado, 2024
You need to define your whitening/brightening positioning, target tone concerns (dullness, spots, uneven tone), tolerance level, and texture (gel-cream vs rich cream) before we start development
While the move still needs the final stamp of approval from the FDA, placing these peptides in that less restricted category will allow compounders to create and sell these medications before their safety and effectiveness has been proven